Evaluation of bovine spongiform encephalopathy risk via the use of materials of bovine origin in or during the manufacture of vaccines

  • Email
  • Help
Current version

Public statement

Reference numberCPMP/BWP/476/01
Published28/02/2001
KeywordsBovine spongiform encephalopathy (BSE), risk, vaccine
DescriptionThis document adresses the safety of the use of bovine-origin materials in vaccines. It concludes that the risk of BSE contamination of vaccines used within the European Union is extremely low thanks to the safety measures being taken.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more